(Q44846498)
Statements
PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients (English)
Yasushi Yatabe
1 reference
Hideki Endoh
Takayuki Kosaka
Hiroyuki Kuwano
Tetsuya Mitsudomi
Yasushi Yatabe
1 September 2006